Christine A. Meda

Diagnostic Products Corp. provides immunodiagnostic systems, which includes IMMULITE series of immunoassay systems, more than 75 immunoassays. It also designs and manufactures automated laboratory instrumentation and automation solutions. Diagnostic Products is located in Los Angeles, CA.

Arcxis Biotechnologies, Inc. develops and distributes molecular diagnostic products. It products include Xisyl workstation, a nucleic acid sample preparation platform; and BioPhalanx analysis workstation, an automated sample-to-result system for clinical laboratory workflows. The company product applications include genetics, cancer, cardiac diseases, infectious diseases, viral diseases, multi-system diseases, biomarkers, pharmacogenomics, and proteomics. The company was founded by Robert H. Smith, Jay A. A. West, John Joseph Jansen, Kyle W. Hukari and Brent C. Satterfield in 2004 and is headquartered in Pleasanton, CA.

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

Diamics Inc. is a medical technology company located in the San Francisco Bay Area. As an innovator in women’s health, the company develops breakthrough cancer diagnostic systems. Diamics’ management team has an extensive track record of success in the medical device, diagnostics and biotechnology industries. The company’s mission is to constantly improve cancer screening diagnostics and provide solutions for unmet medical needs in women’s health. Diamics has two products in near term (6-12 months) development timelines. One product, the TouchPap™, focuses on improving the ubiquitous Pap test and is scheduled for launch in 2009. Following on the heels of this launch will be products aimed at the rapidly expanding molecular diagnostics market, specifically targeting HPV and cervical cancer.

IncellDx, Inc. detects and monitors life threatening diseases. It offers transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. The company was founded by Bruce K. Patterson and Carol Penfold-Patterson on December 3, 2009 and is headquartered in Menlo Park, CA.

RxDx Link operates as a consulting firm serving start-up, early stage, and mid-size biotechnology companies in the diagnostic, medical device and pharmaceutical industries. The company was founded by Christine A. Meda in 2007 and is headquartered in U.S.